Protagenic Therapeutics Stock Filter Stocks by Fundamentals
PTIX Stock | USD 0.65 0.04 6.56% |
Protagenic Therapeutics fundamentals help investors to digest information that contributes to Protagenic Therapeutics' financial success or failures. It also enables traders to predict the movement of Protagenic Stock. The fundamental analysis module provides a way to measure Protagenic Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Protagenic Therapeutics stock.
Protagenic |
Did you try this?
Run Watchlist Optimization Now
Watchlist OptimizationOptimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |
All Next | Launch Module |
Protagenic Fundamentals
Return On Equity | -2.06 | ||||
Return On Asset | -0.9 | ||||
Current Valuation | (721.57 K) | ||||
Shares Outstanding | 6.79 M | ||||
Shares Owned By Insiders | 14.24 % | ||||
Shares Owned By Institutions | 5.76 % | ||||
Number Of Shares Shorted | 89.12 K | ||||
Price To Earning | 9.43 X | ||||
Price To Book | 5.75 X | ||||
EBITDA | (4.5 M) | ||||
Net Income | (5 M) | ||||
Cash And Equivalents | 8.87 M | ||||
Cash Per Share | 0.51 X | ||||
Total Debt | 655.25 K | ||||
Debt To Equity | 0.04 % | ||||
Current Ratio | 19.47 X | ||||
Book Value Per Share | 0.83 X | ||||
Cash Flow From Operations | (3.7 M) | ||||
Short Ratio | 1.33 X | ||||
Earnings Per Share | (1.27) X | ||||
Target Price | 4.0 | ||||
Beta | 0.25 | ||||
Market Capitalization | 4.04 M | ||||
Total Asset | 4.32 M | ||||
Retained Earnings | (30.78 M) | ||||
Working Capital | 3.54 M | ||||
Current Asset | 3.75 M | ||||
Current Liabilities | 736 K | ||||
Net Asset | 4.32 M |
About Protagenic Therapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Protagenic Therapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Protagenic Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Protagenic Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Protagenic Stock Analysis
When running Protagenic Therapeutics' price analysis, check to measure Protagenic Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Protagenic Therapeutics is operating at the current time. Most of Protagenic Therapeutics' value examination focuses on studying past and present price action to predict the probability of Protagenic Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Protagenic Therapeutics' price. Additionally, you may evaluate how the addition of Protagenic Therapeutics to your portfolios can decrease your overall portfolio volatility.